Table 6 The association of demographic, social, education, and clinical factors with emotion-oriented coping and with avoidant-distracted coping (assessed according to the CISS questionnaire) in the study group.
Variable | Emotion-oriented coping | p | Avoidant-distracted coping | p | ||
|---|---|---|---|---|---|---|
Low or average [n = 21] | High [n = 8] | Low [n = 4] | Average or high [n = 25] | |||
Sex | ||||||
Women | 15 (71.4%) | 6 (28.6%) | 0.7853 | 3 (14.3%) | 18 (85.7%) | 0.6328 |
Men | 6 (75%) | 2 (25%) | 1 (12.5%) | 7 (87.5%) | ||
Age [years], Median [IQR] (Min-Max) | 36 [26-44.8] | 45 [29–58] | 0.3660 | 34.5 [21–51] | 36 [29.8–47.3] | 0.6806 |
Place of residence | ||||||
City | 13 (72.2%) | 5 (27.8%) | 0.6902 | 4 (22.2%) | 14 (77.8%) | 0.2589 |
Village | 8 (72.7%) | 3 (27.3%) | 0 (0%) | 11 (100%) | ||
Education | ||||||
Primary, vocational, secondary | 10 (66.7%) | 5 (33.3%) | 0.7634 | 3 (20%) | 12 (80%) | 0.6423 |
Higher | 11 (78.6%) | 3 (21.4%) | 1 (7.1%) | 13 (92.9%) | ||
Scales on exposed parts of the body | ||||||
No | 9 (69.2%) | 4 (30.8%) | 0.9426 | 0 (0%) | 13 (100%) | 0.1614 |
Yes | 12 (75%) | 4 (25%) | 4 (25%) | 12 (75%) | ||
Itching, Median [IQR] (Min-Max) | 4 [3-6.3] | 6 [3–8] | 0.4450 | 6 [3–8] | 4 [3-7.3] | 0.6780 |
Exfoliation, Median [IQR] (Min-Max) | 7 [4–9] | 8 [6–10] | 0.3118 | 6 [3.5–8.5] | 7 [4-9.3] | 0.6315 |
Redness, Median [IQR] (Min-Max) | 5 [3–6] | 7.5 [5-8.5] | 0.0385* | 5 [2.5-6] | 5 [3.8–7.3] | 0.5655 |
The whole body is covered in scales | ||||||
No | 11 (73.3%) | 4 (26.7%) | 0.7634 | 0 (0%) | 15 (100%) | 0.0909 |
Yes | 10 (71.4%) | 4 (28.6%) | 4 (28.6%) | 10 (71.4%) | ||
Infiltrations | ||||||
No | 13 (76.5%) | 4 (23.5%) | 0.8729 | 2 (11.8%) | 15 (88.2%) | 0.8653 |
Yes | 8 (66.7%) | 4 (33.3%) | 2 (16.7%) | 10 (83.3%) | ||
Color of scales | ||||||
Beige, yellow or brown | 15 (68.2%) | 7 (31.8%) | 0.6756 | 2 (9.1%) | 20 (90.9%) | 0.5012 |
White | 6 (85.7%) | 1 (14.3%) | 2 (28.6%) | 5 (71.4%) | ||
% of body surface covered in lesions, Median [IQR] (Min-Max) | 90% [42.5-100%] | 90% [4-100%] | 0.8016 | 100% [99-100%] | 80% [9-100%] | 0.0546 |
Pain, Median [IQR] (Min-Max) | 2 [1-5.5] | 2.5 [1–6] | 0.6207 | 3 [1.5-6] | 2 [0.8–5.5] | 0.4415 |
Increased sweating | ||||||
No | 12 (63.2%) | 7 (36.8%) | 0.2713 | 2 (10.5%) | 17 (89.5%) | 0.8912 |
Yes | 9 (90%) | 1 (10%) | 2 (20%) | 8 (80%) | ||
Ectropion | ||||||
No | 16 (76.2%) | 5 (23.8%) | 0.7853 | 2 (9.5%) | 19 (90.5%) | 0.6328 |
Yes | 5 (62.5%) | 3 (37.5%) | 2 (25%) | 6 (75%) | ||
Sleep disorders | ||||||
No | 15 (78.9%) | 4 (21.1%) | 0.5170 | 3 (15.8%) | 16 (84.2%) | 0.8912 |
Yes | 6 (60%) | 4 (40%) | 1 (10%) | 9 (90%) | ||
Inability to fully close the eyelids | ||||||
No | 9 (75%) | 3 (25%) | 0.8729 | 2 (16.7%) | 10 (83.3%) | 0.8653 |
Yes | 12 (70.6%) | 5 (29.4%) | 2 (11.8%) | 15 (88.2%) | ||
Feeling of ear plugging | ||||||
No | 14 (87.5%) | 2 (12.5%) | 0.1099 | 1 (6.2%) | 15 (93.7%) | 0.4440 |
Yes | 7 (53.8%) | 6 (46.2%) | 3 (23.1%) | 10 (76.9%) | ||
Hearing loss | ||||||
No | 18 (78.3%) | 5 (21.7%) | 0.3862 | 3 (13%) | 20 (87%) | 0.6632 |
Yes | 3 (50%) | 3 (50%) | 1 (16.7%) | 5 (83.3%) | ||
Performance status (Karnofsky scale), Median [IQR] (Min-Max) | 90 [70–100] | 75 [42.5–92.5] | 0.2146 | 90 [62.5–97.5] | 90 [57.5–100] | 0.8976 |
